Optimum Medical Treatment

Optimum Medical Treatment

“Quadruple Medical Therapy”

Current international guidelines recommend the combined use of four different drug classes in systolic heart failure. This combination both extends life expectancy and significantly reduces the risk of hospitalization.

Drug Class

How It Works?

Benefit

ARNI (Sacubitril/Valsartan)

Reduces pressure on the heart, increases protective hormones

Reduces the risk of death by 20%

Beta-Blocker

Regulates heart rate, protects the heart

Lowers the risk of sudden death

MRA (Mineralocorticoid Antagonist)

Combats fluid retention, protects the heart against remodeling

Reduces hospitalization

SGLT2 Inhibitor

Excretes harmful fluids and salts through the kidneys

Reduces cardiovascular death

Important: These medications complement one another. They must be initiated under physician supervision, dosages should be titrated gradually, and they should never be stopped on your own.

This content is intended for general informational purposes only. Diagnostic and treatment decisions must be individually evaluated by a specialist cardiologist.

Heart Failure and Risk Analysis

Book an Appointment!

TR|EN